Ultragenyx Pharmaceutical Inc. awarded 44,409 restricted stock units to 15 newly hired non-executive officers under its Employment Inducement Plan. The grants, approved by the compensation committee, vest over four years with 25% vesting annually, contingent on continued employment. This move aims to attract and retain talent as Ultragenyx continues developing therapies for rare diseases. The inducement follows Nasdaq Listing Rule 5635(c)(4) requirements.
Nyxoah has announced an extraordinary general meeting of shareholders set for July 9, 2026, at its headquarters in Belgium. The meeting will discuss renewing the authorization for the board to increase the company's capital over the next five years, ...
Eupraxia Pharmaceuticals held its Annual General Meeting on June 18, 2026, where shareholders elected all seven board nominees proposed by management with strong majority votes. Additionally, KPMG LLP was reappointed as the company's auditor for the ...
Cate & Chloe is discounting its Bianca 18k Gold-Plated Crystal Hoop Earrings to $19.98 from $86 during Amazon Prime Day 2026, running June 23-26. This 77% markdown aligns with growing consumer demand for affordable luxury jewelry, with earrings price...
SPX Technologies announced a leadership transition in its Detection & Measurement segment as John Swann plans to retire in January 2027. Eric Kaled will take over as segment leader starting August 31, 2026, ensuring continuity and growth. Swann has b...
GoMining has introduced GoBTC Pay, a Bitcoin payment infrastructure that settles transactions directly on the Bitcoin network without converting to fiat currency. The system charges merchants a low 0.2% processing fee, significantly undercutting trad...
